A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review.

Renato Ferreira-da-Silva Joana Reis-Pardal Manuela Pinto Matilde Monteiro Soares Bernardo Sousa-Pinto Manuela Morato Jorge Junqueira Polónia Inês Ribeiro-Vaz

Published in: Drug safety (2024)

DEM was the predominant pharmacovigilance strategy, employing multiple data sources, and appears to increase the likelihood of detecting higher AE incidence. Establishing such a framework would facilitate a more detailed and consistent approach across different studies and settings.

Keyphrases

adverse drug
electronic health record
drug induced
risk factors
drinking water
big data
case control
emergency department
machine learning
data analysis
deep learning